These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 33904857)

  • 1. Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database.
    Renoud L; Khouri C; Revol B; Lepelley M; Perez J; Roustit M; Cracowski JL
    JAMA Intern Med; 2021 Sep; 181(9):1243-1245. PubMed ID: 33904857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
    Kim JE; Park J; Min YG; Hong YH; Song TJ
    J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: A comprehensive analysis of the international pharmacovigilance database.
    Lee S; Lee K; Park J; Jeong YD; Jo H; Kim S; Woo S; Son Y; Kim HJ; Lee K; Ha Y; Oh NE; Lee J; Rhee SY; Smith L; Kang J; Rahmati M; Lee H; Yon DK
    J Med Virol; 2024 Jul; 96(7):e29792. PubMed ID: 38993028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database.
    Kamath A; Maity N; Nayak MA
    Clin Drug Investig; 2020 Sep; 40(9):883-889. PubMed ID: 32696320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database.
    Jeong YD; Lee K; Lee S; Park J; Kim HJ; Lee J; Kang J; Jacob L; Smith L; Rahmati M; López Sánchez GF; Dragioti E; Son Y; Kim S; Yeo SG; Lee H; Yon DK
    J Med Virol; 2024 Jun; 96(6):e29682. PubMed ID: 38783823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database.
    Lee S; Jo H; Lee H; Lee H; Lee J; Kim HJ; Kang J; Jacob L; Smith L; Rahmati M; López Sánchez GF; Dragioti E; Jeon H; Cho JM; Choi Y; Park J; Woo S; Yon DK
    J Med Virol; 2024 Jun; 96(6):e29693. PubMed ID: 38859751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database.
    Kim MS; Jung SY; Ahn JG; Park SJ; Shoenfeld Y; Kronbichler A; Koyanagi A; Dragioti E; Tizaoui K; Hong SH; Jacob L; Salem JE; Yon DK; Lee SW; Ogino S; Kim H; Kim JH; Excler JL; Marks F; Clemens JD; Eisenhut M; Barnett Y; Butler L; Ilie CP; Shin EC; Il Shin J; Smith L
    J Med Virol; 2022 Mar; 94(3):1085-1095. PubMed ID: 34709664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A disproportionality analysis for the association of central nervous system demyelinating diseases with COVID-19 vaccination using the World Health Organization pharmacovigilance database.
    Kim JE; Park J; Song TJ
    Mult Scler; 2022 Nov; 28(13):2112-2123. PubMed ID: 35822296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.
    de Germay S; Singier A; Salvo F; Pariente A;
    Drug Saf; 2023 Dec; 46(12):1381-1389. PubMed ID: 37926785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
    Shakir S; Lane S; Davies M
    Drug Saf; 2021 Jan; 44(1):1-5. PubMed ID: 33219926
    [No Abstract]   [Full Text] [Related]  

  • 11. French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge.
    Lacroix C; Salvo F; Gras-Champel V; Gautier S; Massy N; Valnet-Rabier MB; Grandvuillemin A; Mounier C; Benkebil M; Pariente A; Jonville-Béra AP; Micallef J;
    Therapie; 2021; 76(4):297-303. PubMed ID: 34059351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database.
    Montastruc JL
    Br J Clin Pharmacol; 2024 Jun; 90(6):1525-1528. PubMed ID: 38627211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Aug; 63(1630):121. PubMed ID: 34550109
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral facial palsy following COVID-19 vaccination: a practical approach to use the clinical situation as a guide.
    Foirest C; Bihan K; Tankéré F; Junot H; Demeret S; Debs R; Maillart E; Lebrun-Frenay C; Vigouroux A; Caudron M; Canouï E; Lamas G; Weiss N; Pourcher V
    Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):300-303. PubMed ID: 35880371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety Profile of Sclerosing Agents: An Analysis From the World Health Organization Pharmacovigilance Database VigiBase.
    Roselli A; Khouri C; Roustit M; Blaise S; Cracowski JL
    Dermatol Surg; 2019 Dec; 45(12):1517-1528. PubMed ID: 30829775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine.
    J Emerg Med; 2022 Mar; 62(3):426. PubMed ID: 35065856
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases.
    Khouri C; Petit C; Tod M; Lepelley M; Revol B; Roustit M; Cracowski JL
    J Clin Epidemiol; 2021 Jun; 134():14-21. PubMed ID: 33508405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An artificial intelligence algorithm for co-clustering to help in pharmacovigilance before and during the COVID-19 pandemic.
    Destere A; Marchello G; Merino D; Othman NB; Gérard AO; Lavrut T; Viard D; Rocher F; Corneli M; Bouveyron C; Drici MD
    Br J Clin Pharmacol; 2024 May; 90(5):1258-1267. PubMed ID: 38332645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series.
    Chamboux M; Simon C; Beau-Salinas F; Maurier A; Agier MS; Thillard EM; Largeau B; Jonville-Bera AP
    Therapie; 2023; 78(6):705-709. PubMed ID: 36849281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data.
    Atzenhoffer M; Auffret M; Pegat A; Masmoudi K; Khouri C; Bertin B; Vial T
    Clin Drug Investig; 2022 Jul; 42(7):581-592. PubMed ID: 35676452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.